Glycemic variability assessed by continuous glucose monitoring and antiplatelet responsiveness in patients undergoing coronary stenting: results from the observational GLYVAR study

Back

ESC Premium Access

Glycemic variability assessed by continuous glucose monitoring and antiplatelet responsiveness in patients undergoing coronary stenting: results from the observational GLYVAR study

Session: Antithrombotic strategies in coronary artery disease

Topic: Thrombosis and coagulation

Speaker: Doctor A. Nusca (Rome, IT)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Doctor Annunziata Nusca

University Campus Bio-Medico of Rome, Rome (Italy)

0 follower

9 more presentations in this session

Antithrombotic treatment in patients with stable CAD and AF - 5-year follow-up data from the CLARIFY registry

Speaker: Doctor R. Wakili (Frankfurt, DE)

Application of DAPT score to predict ischaemic and bleeding events in patients who underwent drug-eluting stent implantation: a landmark analysis of large pooled cohort

Speaker: Doctor Y. Yoshikawa (Kyoto, JP)

Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.

Speaker: Doctor M. Bonaca (Aurora, US)

In-hospital switch of P2Y12 drugs in patients presenting with acute coronary syndrome: a meta-analysis of 14 observational and randomized studies including 10961 patients.

Speaker: Doctor M. Bianco (Orbassano, IT)

Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: OLTAT registry

Speaker: Doctor Q. Fischer (Paris, FR)

Access the full session

Antithrombotic strategies in coronary artery disease

Speakers: Doctor A. Nusca, Doctor R. Wakili, Doctor Y. Yoshikawa, Doctor M. Bonaca, Doctor M. Bianco...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

Glycemic variability assessed by continuous glucose monitoring and antiplatelet responsiveness in patients undergoing coronary stenting: results from the observational GLYVAR study

About the speaker

Doctor Annunziata Nusca

9 more presentations in this session

Antithrombotic treatment in patients with stable CAD and AF - 5-year follow-up data from the CLARIFY registry

Application of DAPT score to predict ischaemic and bleeding events in patients who underwent drug-eluting stent implantation: a landmark analysis of large pooled cohort

Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.

In-hospital switch of P2Y12 drugs in patients presenting with acute coronary syndrome: a meta-analysis of 14 observational and randomized studies including 10961 patients.

Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: OLTAT registry

Access the full session

Antithrombotic strategies in coronary artery disease

About the event

ESC Congress 2017

ESC 365 is supported by